Analyst Ratings for Relay Therapeutics (RLAY)
RLAY Rating Summary
RLAY Price Target Summary
- Highest: $31.00 (Goldman Sachs)
- Lowest: $18.00 (Oppenheimer)
- Average: $24.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$24.50 (+30.7%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/16/2026 | Canaccord | John Newman | New Coverage | Buy (N/A) |
29.00 (N/A) |
19.51 (18.75) |
-3.9% | Details |
| 7/8/2026 | JPMorgan | Priyanka Grover | New Coverage | Overweight (N/A) |
28.00 (N/A) |
18.90 (18.75) |
-0.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
